The Court Supports Bavarian Nordic's Decision to Start Patent Infringement Case Against Oxford BioMedica
Novavax Reports First Quarter 2009 Financial Results
Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2009 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.